DFDS A/S
Investor news no. 05/2021 |
DFDS expects to publish the report for Q4 2020 on 10 February 2021 at around 08:00 AM CET.
Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call.
The presentation in English will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part.
Date: 10 February 2021
Time: 10:00 AM CET
Telephone DK +45 35445577
UK +44 33 33000804
US +1 631 913 1422
List of international numbers:
https://event.sharefile.com/d-s451667d1ca54c838
Access code: 81772821#
If you wish to take part in the audio conference, please dial up at least five minutes before the conference begins. It will start on time, and participants will be asked to register name and company name beforehand.
The conference will be broadcast live on https://www.dfds.com/en/about and published there for future reference.
Contact
Søren Brøndholt Nielsen, IR +45 33 42 33 59
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG19.10.2025 16:30:00 CEST | Press release
PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom